Annotation Detail for ZBED2
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016718 |
Arachidonic Acid |
Arachidonic Acid results in decreased expression of ZBED2 mRNA | decreases expression | 16704987
|
| D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of ZBED2 mRNA | affects cotreatment|decreases expression | 17404688
|
| D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of ZBED2 mRNA | affects cotreatment|decreases expression | 17404688
|
| D011374 |
Progesterone |
Progesterone results in increased expression of ZBED2 mRNA | increases expression | 17404688
18070364
|
| C034613 |
triacsin C |
triacsin C results in decreased expression of ZBED2 mRNA | decreases expression | 16704987
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.17 | 11473722 |
| MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
3.00 | 18582451 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
6.06 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.82 | 15380490 15665606 15845082 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.17 | 17289903 17018787 18497071 12948864 14630087 17261762 19861407 16675129 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.17 | 16175315 17614352 15562024 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.09 | 16111702 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.79 | 16924424 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
3.03 | 18566989 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.78 | 19279558 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
5.05 | 17187935 |
| MESH:D004487 |
Edema |
|
Arachidonic Acid |
4.46 | 7990266 15177302 9599246 11698051 16716910 9831321 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.28 | 17692515 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.22 | 19148513 18566989 11473722 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
4.16 | 16134523 |
| MESH:D005334 |
Fever |
|
Arachidonic Acid |
5.05 | 11852909 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.76 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.47 | 17088409 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.96 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
6.19 | 9831321 15177302 17371808 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
6.19 | 15869954 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.21 | 16393666 16627594 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.78 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.32 | 15610895 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14659978 14716833 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.86 | 11807958 11408345 16891317 17203775 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.86 | 17203775 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.21 | 19453300 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.59 | 16810080 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.36 | 17289903 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.16 | 11399458 16427766 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.20 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.20 | 16525653 17393432 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.31 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.02 | 16740699 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.96 | 18045962 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.91 | 16503802 15862959 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.41 | 19048282 |
Related Pathway Information